Hydrazones as novel epigenetic modulators: Correlation between TET 1 protein inhibition activity and their iron(II) binding ability-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hydrazones as novel epigenetic modulators: Correlation between TET 1 protein inhibition activity and their iron(II) binding ability

Published:2019-07 Issue: Volume:88 Page:102809
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Jakubek Milan,Kejík Zdeněk,Kaplánek Robert,Antonyová Veronika,Hromádka Róbert,Šandriková Viera,Sýkora David,Martásek Pavel,Král Vladimír

Funder

Ministry of Education, Youth and Sports of the Czech Republic

Technology Agency of the Czech Republic

Ministry of Industry and Trade

Ministry of Agriculture of the Czech Republic

Charles University in Prague

Operational Programme Prague – Competitiveness

National Programme of Sustainability I

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference32 articles.

1. Pharmacogenomics of Alzheimer's and Parkinson's diseases;Cacabelos;Neurosci. Lett.,2018

2. Novel epigenetic-sensitive clinical challenges both in type 1 and type 2 diabetes;Sommese;J. Diabetes Compl.,2018

3. Histone deacetylase inhibitors and diabetic kidney disease;Hadden;Int. J. Mol. Sci.,2018

4. Epigenetic agents in combined anticancer therapy;Kejik;Future Med. Chem.,2018

5. New Insights into 5hmC DNA modification: generation, distribution and function;Shi;Front. Genet.,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron chelators as mitophagy agents: Potential and limitations;Biomedicine & Pharmacotherapy;2024-10

2. TET protein inhibitors: Potential and limitations;Biomedicine & Pharmacotherapy;2023-10

3. Epidrugs in the Therapy of Central Nervous System Disorders: A Way to Drive on?;Cells;2023-05-24

4. Preparation of Tryptanthrin Derivates Bearing a Thiosemicarbazone Moiety to Inhibit SARS-CoV-2 Replication;Separations;2023-01-20

5. Epigenetic therapy of cancer;Medicinal Chemistry of Anticancer Drugs;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3